Reactogenicity of Enhanced Influenza Vaccines in Older Adults
A team of investigators report on the findings from a randomized controlled trial of 3 enhanced influenza vaccines and a standard-dose vaccine in older adults.
Influenza
Monitoring for Trends in COVID-19 Needed
In response to the COVID-19 pandemic, New York State implemented a series of community mitigation strategies, and monitoring approaches are needed to assess the effect of these interventions.
Cell-Cultured Superior to Egg-Derived Influenza Vaccine
Cell-cultured quadrivalent influenza vaccines may have greater effectiveness compared with standard, egg-derived quadrivalent influenza vaccines.
Influenza Vaccine Not Linked to Decrease in Hospitalizations or Mortality Among Elderly
Targeting the elderly (individuals aged 65 years) for influenza vaccination may not decrease hospitalization or mortality rates in this population.
Poorer Clinical Outcomes in COVID-19 Driven by Comorbidities
In laboratory-confirmed cases of COVID-19, patients with any comorbidities have experienced poorer clinical outcomes compared with those without comorbidities.
COVID-19 vs H1N1 Influenza: A Clinical Characteristic Comparison
Hospitalized patients withCOVID-19 had higher proportions of nonproductive cough, fatigue, and gastrointestinal symptoms as well as lower severity of illness scores compared with patients with H1N1 influenza.
Contribution of Leaky Vaccine Effect to Influenza Effectiveness
The observed intra-seasonal decreases of measured influenza vaccine effectiveness was only partially accounted for by leaky vaccine bias.
Face Masks Offer Slight Protective Effect From Flu-Like Illness
Wearing face masks could be slightly protective against primary infection with influenza-like illness from casual community contact.
Frequency and Factors Associated With Hospital Readmissions Due to Influenza
Hospitalization due to influenza leads to a high likelihood of readmission within 30 days and 1 year with cardiovascular, respiratory, and infectious etiologies being the most common.
Universal FLU-v Influenza Vaccine, Immunogenic and Warrants Further Testing
The adjuvanted, broad-spectrum influenza vaccine FLU-v was found to be immunogenic and merits phase 3 development to explore efficacy.
-
Loading...
-
Loading...
Next post in Influenza
